Jean Nordstrom of Sixera Pharma AB
joined us for World Orphan Drug Congress USA 2015 to present about '
Restoring Skin Barrier Function: New Treatment for Netherton Syndrome'
Download the presentation now to learn about:
Unmet medical need and market
In Vivo proof of principle
Project status and next steps
Get your copy here!
To find out more about how
Sixera Pharma AB's new treatment for Netherton Syndrome
, join us at
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.
Remember my details
Privacy statement »
Manage your email preferences »
You will be emailed the document as an attachment (3,187Kb in size)